Qualigen Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q2 2023.
  • Qualigen Therapeutics, Inc. Depreciation for the quarter ending June 30, 2023 was $19K, a 20.8% decline year-over-year.
  • Qualigen Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2023 was $84K, a 4.55% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2022 was $92K, a 26% increase from 2021.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2021 was $73K.
  • Qualigen Therapeutics, Inc. annual Depreciation for 2019 was $6.1K, a 7.02% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $84K $19K -$5K -20.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $89K $20K -$3K -13% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $92K $21K -$1K -4.55% Oct 1, 2022 Dec 31, 2022 10-K 2023-05-02
Q3 2022 $93K $24K +$5K +26.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $88K $24K +$7K +41.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $81K $23K +$8K +53.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $73K $22K Oct 1, 2021 Dec 31, 2021 10-K 2023-05-02
Q3 2021 $19K +$9K +90% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $17K +$8K +88.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $15K +$5K +50% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 -$300 $10K -$7K -41.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $6.7K $9K -$8K -47.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $14.7K $10K +$8.6K +614% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $6.1K -$29.3K -$30.7K -2193% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-31
Q3 2019 $36.8K $17K +$15.5K +1033% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $21.3K $17K +$15.6K +1114% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $5.7K $1.4K $0 0% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $5.7K $1.4K -$413 -22.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-31
Q3 2018 $6.11K $1.5K +$200 +15.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.91K $1.4K +$100 +7.69% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $5.81K $1.4K +$93.00 +7.12% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $5.72K $1.81K +$458 +33.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $5.26K $1.3K $0 0% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.26K $1.3K $0 0% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $5.26K $1.31K +$53.00 +4.23% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $5.21K $1.36K +$419 +44.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 $4.79K $1.3K +$900 +225% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $3.89K $1.3K +$1K +333% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $2.89K $1.25K +$951 +314% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $1.94K $936 Oct 1, 2015 Dec 31, 2015 10-K 2017-02-27
Q3 2015 $400 Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $300 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $303 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.